luminescence. Conversely, (c) the synthetic N-terminal peptide ORAI1(66-91), 10-30 µM, was able to reverse the STIM1-dependent increase in luminescence, reducing luminescence to the level of Tb 3+ bound to ORAI1 prior to STIM1 CT addition, but (d) the peptide had no effect on the luminescence of Tb 3+ bound to ORAI1 in the absence of CT , loaded at the bottom of a discontinuous sucrose density gradient, and subjected to ultracentrifugation. Individual gradient fractions were analyzed for ORAI1 and STIM1
CT by western blotting using anti-FLAG and anti-STIM1 antibodies, respectively. 
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